NAT2 gene polymorphisms in three indigenous groups in the Colombian Caribbean Coast region

Objective: To study the NAT 2 gene polymorphisms 481T, 590A and 857A in the Chimila, Wiwa and Wayuu indigenous groups of the Colombian Caribbean to determine the frequencies of the alleles NAT2*4, NAT2*5, NAT2*6, and NAT2*7 and to determine the types of acetylators present in these populations. Meth...

Full description

Autores:
Arias I.
Lecompte N.
Visbal L.
Curiel I.
Hernandez Aguirre, Enio
Garavito P.
Silvera-Redondo C.
Tipo de recurso:
Article of journal
Fecha de publicación:
2023
Institución:
Universidad Cooperativa de Colombia
Repositorio:
Repositorio UCC
Idioma:
OAI Identifier:
oai:repository.ucc.edu.co:20.500.12494/49695
Acceso en línea:
https://doi.org/10.25100/cm.v45i4.1563
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84921926737&partnerID=40&md5=d30772305d3e69be448b6566367ee5de
https://hdl.handle.net/20.500.12494/49695
Palabra clave:
ACETYLATION
ACETYLATOR PHENOTYPE
ALLELE
ALLELES
AMERICAN INDIAN
ARTICLE
ARYLAMINE ACETYLTRANSFERASE
ARYLAMINE N-ACETYLTRANSFERASE
CARIBBEAN
COLOMBIA
COLOMBIAN
FEMALE
GENE
GENE FREQUENCY
GENETIC VARIABILITY
GENETICS
GENOMIC DNA
HAPLOTYPE
HUMAN
HUMANS
INDIANS, SOUTH AMERICAN
MALE
NAT2 GENE
NAT2 PROTEIN, HUMAN
PHARMACOGENETICS
POLYMORPHISM, SINGLE NUCLEOTIDE
REAL TIME POLYMERASE CHAIN REACTION
REAL-TIME POLYMERASE CHAIN REACTION
SINGLE NUCLEOTIDE POLYMORPHISM
Rights
openAccess
License
http://purl.org/coar/access_right/c_abf2
Description
Summary:Objective: To study the NAT 2 gene polymorphisms 481T, 590A and 857A in the Chimila, Wiwa and Wayuu indigenous groups of the Colombian Caribbean to determine the frequencies of the alleles NAT2*4, NAT2*5, NAT2*6, and NAT2*7 and to determine the types of acetylators present in these populations. Methods: A total of 202 subjects were studied: 47 Chimila, 55 Wiwa, and 100 Wayuu. Te polymorphisms were identifed using a real-time PCR method for allelic discrimination designed using Taqman of Applied Biosystems. Results: Te following alleles were found at the highest frequency in the following groups: the NAT2*4 allele (wild type) in the Wayuu group (55.3%), the NAT2*5 allele in the Wiwa group (34.5%), and the NAT2*7 allele in the Chimila group (24.2%). A higher frequency of the rapid acetylator status was found in the Wayuu group (31.3%) and Chimila group (29.5%) compared with the Wiwa group (12.7%). Te intermediate acetylator status distribution was very similar in all three groups, and the frequency of the slow acetylator status was higher in the Wiwa group (32.7%) compared with the Chimila and Wayuu groups (20.5% and 21.2%, respectively). Conclusion: Te results demonstrated the allelic distribution and pharmacogenetic diferences of the three groups studied and revealed the most frequent acetylator status and phenotype. Because of the high prevalence of slow acetylators, a greater incidence of tuberculosis (TB) drug-induced hepatotoxicity is predicted in these populations, with a higher frequency in the Wiwa group. © 2014 Universidad del Valle.